Cargando…

Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer

Mostrar otras versiones (1)

Prostate cancer (PCa) is the most common cancer type in men worldwide. Currently, the management of metastatic PCa (mPCa) remains a challenge to urologists. The analysis of hub genes and pathways may facilitate the understanding of the molecular mechanism of PCa. In the present study, to identify th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Junhao, Chen, Zhi, Li, Zuan, Nong, Deyong, Li, Ximing, Huang, Guihai, Hao, Nan, Liang, Jianbo, Li, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317150/ https://www.ncbi.nlm.nih.gov/pubmed/34296309 http://dx.doi.org/10.3892/or.2021.8147

Ejemplares similares

Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer
por: Lin, Junhao, et al.
Publicado: (2022)

CD44 regulates prostate cancer proliferation, invasion and migration via PDK1 and PFKFB4
por: Li, Wei, et al.
Publicado: (2017)

Effect of AKT silence on malignant biological behavior of renal cell carcinoma cells
por: Li, Zuan, et al.
Publicado: (2022)

The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue
por: Li, Ximing, et al.
Publicado: (2020)

Speckle-type POZ protein could play a potential inhibitory role in human renal cell carcinoma
por: Chen, Zhi, et al.
Publicado: (2022)

High expression of TTC21A predicts unfavorable prognosis and immune infiltrates in clear cell renal cell carcinoma
por: Lin, Junhao, et al.
Publicado: (2022)

Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells
por: Desai, Bhavik, et al.
Publicado: (2007)

Intratumoral immune heterogeneity of prostate cancer characterized by typing and hub genes
por: Han, Jianpeng, et al.
Publicado: (2022)

Development and validation of hub genes for lymph node metastasis in patients with prostate cancer
por: Xu, Ning, et al.
Publicado: (2020)

ComHub: Community predictions of hubs in gene regulatory networks
por: Åkesson, Julia, et al.
Publicado: (2021)

A new finding in the key prognosis-related proto-oncogene FYN in hepatocellular carcinoma based on the WGCNA hub-gene screening trategy
por: Huang, Chenkai, et al.
Publicado: (2022)

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
por: Li, Zhonghu, et al.
Publicado: (2014)

In Vitro and In Vivo Prostate Cancer Metastasis and Chemoresistance Can Be Modulated by Expression of either CD44 or CD147
por: Hao, Jingli, et al.
Publicado: (2012)

Identification of hub genes and pathways in lung metastatic colorectal cancer
por: Dai, Wei, et al.
Publicado: (2023)

Evaluation of CD44 Expression in Prostatic Adenocarcinoma: An Institutional Study
por: Damarasingu, Priyanka V, et al.
Publicado: (2023)

Comparative Analysis of Prostate Cancer Gene Regulatory Networks via Hub Type Variation
por: Khosravi, Pegah, et al.
Publicado: (2015)

Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma
por: Wei, Shuxun, et al.
Publicado: (2019)

CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells
por: Li, Linxian, et al.
Publicado: (2016)

New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression
por: Ziranu, Pina, et al.
Publicado: (2023)

Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC
por: Ma, Jing, et al.
Publicado: (2020)

Tumorigenic and Metastatic Role of CD44(−/low)/CD24(−/low) Cells in Luminal Breast Cancer
por: Vikram, Rajeev, et al.
Publicado: (2020)

Investigating altered brain functional hubs and causal connectivity in coronary artery disease with cognitive impairment
por: Qin, Rui, et al.
Publicado: (2023)

The liberation of CD44
por: Cichy, Joanna, et al.
Publicado: (2003)

Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanoma
por: Fänder, Johannes, et al.
Publicado: (2019)

LRRC4 mediates the formation of circular RNA CD44 to inhibitGBM cell proliferation
por: Feng, Jianbo, et al.
Publicado: (2021)

Knockdown of ALDH1A3 reduces breast cancer stem cell marker CD44 via the miR-7-TGFBR2-Smad3-CD44 regulatory axis
por: Pan, Meng, et al.
Publicado: (2021)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Publicado: (1996)

Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer
por: Yang, Dan, et al.
Publicado: (2020)

CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model
por: Mayr, Lisa, et al.
Publicado: (2017)

Screening and identification of hub-gene associated with brain metastasis in breast cancer
por: Li, Xiao-Gang, et al.
Publicado: (2023)

Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis
por: Zhou, Zengyuan, et al.
Publicado: (2019)

Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells
por: Di Stefano, Chiara, et al.
Publicado: (2018)

Oncogenic ASPM Is a Regulatory Hub of Developmental and Stemness Signaling in Cancers
por: Tsai, Kelvin K., et al.
Publicado: (2023)

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

Structural and Functional Analyses of Hub MicroRNAs in An Integrated Gene Regulatory Network of Arabidopsis
por: Gao, Zhaoxu, et al.
Publicado: (2022)

Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells
por: Montero-Montero, Lucía, et al.
Publicado: (2020)

Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
por: Hao, J, et al.
Publicado: (2010)

Connectome and regulatory hubs of CAGE highly active enhancers
por: Briend, Mewen, et al.
Publicado: (2023)

Immunohistochemical Detection of Cancer Stem Cell Related Markers CD44 and CD133 in Metastatic Colorectal Cancer Patients
por: Pitule, Pavel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lbscompvuolf66fuhoepdeba4t